the First Affiliated Hospital of Shantou University Medical College — Shantou

Public research footprint of the First Affiliated Hospital of Shantou University Medical College, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Systemic Lupus Erythematosus · Unresectable or Metastatic Microsatellite Stable/Mismatch Repair… · Rheumatoid Arthritis · Relapsed Diffuse Large B-cell Lymphoma

Recently updated registry entries

NCT07104604 — Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab… (Recruiting)
NCT05609370 — A Study Investigating the Efficacy and Safety of Alcestobart (LBL-007) Plus Tislelizumab… (Active Not Recruiting)
NCT07157774 — Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at the First Affiliated Hospital of Shantou University Medical College?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.